atopic-dermatitis

Documents about atopic-dermatitis

• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis#891304ClinicalTrials.gov
• A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis#899761ClinicalTrials.gov
• MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement#978979ClinicalTrials.gov
• Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis#991711ClinicalTrials.gov
• A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis#843296ClinicalTrials.gov
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India#1010598ClinicalTrials.gov
• A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis#844929ClinicalTrials.gov
• Insulin Sensitivity in Patients With Atopic Dermatitis#387275ClinicalTrials.gov
• CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness#811257ClinicalTrials.gov
• Management of Pruritus With Xyzal in Atopic Dermatitis#811466ClinicalTrials.gov
• A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis#825120ClinicalTrials.gov
• 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis#843097ClinicalTrials.gov
• Study of 0417 Ointment in the Treatment of Atopic Dermatitis#863163ClinicalTrials.gov
• Evalution the Safety and Efficacy in Atopic Dermatitis Patients#869517ClinicalTrials.gov
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis#841808ClinicalTrials.gov
• The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study#968418ClinicalTrials.gov
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)#394604ClinicalTrials.gov
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis#807778ClinicalTrials.gov
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)#825225ClinicalTrials.gov
• Dupixent and Narrowband UVB for Atopic Dermatitis#828156ClinicalTrials.gov
• Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis#883730ClinicalTrials.gov
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis#868758ClinicalTrials.gov
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis#893104ClinicalTrials.gov
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis#870661ClinicalTrials.gov
• Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD#1007197ClinicalTrials.gov
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis#840993ClinicalTrials.gov
• The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis#802824ClinicalTrials.gov
• Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis#828930ClinicalTrials.gov
• A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)#830840ClinicalTrials.gov
• Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis#835195ClinicalTrials.gov
• A Study of Hemay005 in Adult With Atopic Dermatitis#848163ClinicalTrials.gov
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis#866564ClinicalTrials.gov
• IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis#872785ClinicalTrials.gov
• A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis#878614ClinicalTrials.gov
• Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis#879089ClinicalTrials.gov
• An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis#892741ClinicalTrials.gov
• Topical L. Reuteri in Children With Atopic Dermatitis#894475ClinicalTrials.gov
• Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?#907686ClinicalTrials.gov
• Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy#918648ClinicalTrials.gov
• Safety and Efficacy of DNK333 in Atopic Dermatitis Patients#917796ClinicalTrials.gov
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis#910387ClinicalTrials.gov
• A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis#801631ClinicalTrials.gov
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis#828975ClinicalTrials.gov
• Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis#834174ClinicalTrials.gov
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)#834806ClinicalTrials.gov
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis#844685ClinicalTrials.gov
• A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis#853636ClinicalTrials.gov
• Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis#856912ClinicalTrials.gov
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis#876604ClinicalTrials.gov
• Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis#914956ClinicalTrials.gov